New Guinea. We report the first imported case of MVE in Europe. A 23-year-old tourist developed severe encephalitis after having returned to Germany from a long-term trip across the Australian continent. The diagnosis was suspected on the basis of clinical findings and the patient's travel history and was confirmed by serological findings. The patient made a prolonged but complete recovery. Our case coincides with a recently reported spread of MVE virus in Australia. This emphasizes the need for continuous surveillance in areas of endemicity and appropriate protection when traveling through regions in which the MVE virus is endemic.
after the first onset of symptoms, the patient was transferred to our referral unit.
When we attended the patient, he was somnolent and disoriented and had irregular myoclonic jerks that rapidly developed into severe disabling asterixis, suggesting acute basal ganglia involvement. The findings of a full cranial nerve examination were normal. Tendon reflexes were bilaterally and symmetrically increased. The patient had no rash, no lymphadenopathy, and no enlarged liver or spleen.
Examinations of blood samples obtained from the patient revealed an elevated leukocyte count of 12,600 cells/mL with 42% lymphocytes. Erythrocyte and platelet counts, as well as hepatic and renal function parameters, were normal. Lactate dehydrogenase and fibrinogen levels were just above the normal range. The CSF cell count showed pleocytosis with 360 lymphocytes/mL. Glucose and protein levels were normal. Attempts to identify a causative agent by direct microscopy and bacterial, viral, or fungal cultures failed repeatedly. Nuclear magnetic resonance and CT scans of the brain revealed no specific radiological changes.
Laboratory diagnosis. Because MVE or Kunjin (KUN) encephalitis was suspected on the basis of the patient's travel history and clinical presentation, flavivirus-specific serological assays were performed. In Germany, MVE and KUN virus-specific assays were not available, which is usually the case outside areas where those diseases are endemic. However, because antibodies to flaviviruses are known to be broadly crossreactive, the samples were tested using assays based on related flaviviruses. IgG was assayed by immunofluorescence using Vero cells infected with West Nile (WN) virus and St. Louis encephalitis (SLE) virus. IgM was tested by a m-capture ELISA [1] using WN virus as antigen and a biotin-labeled WN virus-specific monoclonal antibody for detection (table 1). The demonstration of specific IgM and increasing IgG titers in CSF and serum samples were consistent with acute MVE/KUN virus infection.
For confirmation of and serological differentiation between MVE and KUN virus, samples were sent to a reference laboratory in Australia. The results of MVE virus-specific ELISA revealed IgM in CSF and serum samples as well as an increase in total antibody levels in the serum, providing strong evidence of acute MVE virus infection. The results of ELISA tests for other flaviviruses were negative. These results were confirmed by neutralization assays, which showed a significant increase in MVE (but not KUN) virus-specific neutralizing antibodies (table 1). Flavivirus RNA could not be detected in serum and CSF samples by PCR, even after ultracentrifugation and application of nested PCR. Both broadrange flavivirus-specific and MVEspecific primers were used. The negative PCR results are consistent with previous case reports [2, 3] that suggest a low virus concentration in CSF and serum during the acute encephalitic phase.
Treatment and outcome. On admission, the patient immediately required artificial respiration and continuous application of anticonvulsive drugs, which had to be continued for a total of 8 days. No specific antiviral treatment was given other than aciclovir therapy for initially presumed acute herpes simplex virus encephalitis. Treatment with the drug was discontinued after 2 days, when the diagnosis of an acute flavivirus infection was established.
Despite the initial severe illness, the patient gradually recovered. For several weeks, he still had intermittent myoclonic jerks that interfered with normal motor activities. Seizure activity was ruled out by electroencephalographic examinations. After 30 days, the patient still experienced muscular twitching and was unable to perform complex manual procedures, including writing. Figure 1 shows his signature 30 and 60 days after the onset of his first symptoms. Two months after the acute stage of the illness, the patient had fully recovered, with no neurological sequelae.
Discussion. MVE virus is a flavivirus of the Japanese encephalitis virus complex, which is transmitted by Culicine mosquitoes. It is the most important cause of arbovirus encephalitis in Australia [4] . MVE virus is related to KUN virus, which is a subtype of the WN virus and is another possible cause of Australian arbovirus encephalitis.
The disease becomes manifest in ∼1 in 1000 infections. Among symptomatic individuals, the case fatality rate can be 120%, with a similarly high rate of residual neurological disability [2, 3, 5, 6] . No specific antiviral treatment is known. Data suggesting a beneficial effect of ribavirin [7] are obtained from in vitro experiments on WN virus and, although the drug crosses the blood-brain barrier [8] , thus far ribavirin's application for MVE has no clinical relevance.
MVE virus is endemic in northwestern Australia. Cases are reported mostly among Aboriginal children and tourists [9] or newcomers to the area. MVE clusters have occurred sporadically in Australia over the last 100 years. Outbreaks are seasonal and occur every few years during or just after the wet season. Occasional spread of MVE virus outside northwestern Australia, where the disease is endemic, to southern Australia (in- [10] , and, in addition, seroconversion in sentinel chicken flocks was reported in NSW for the first time since 1974 (though no cases were reported there among humans) [11, 12] . In 2002, no further cases occurred outside the location in which the disease was endemic. However, spread of MVE virus outside its usual boundaries can happen again in times of vector abundance and suitable climatic conditions [5, 13, 14] . National and local advisories are now issued to inform the public about the potential risks of and precautions against MVE.
Despite the severe initial presentation of MVE, our patient made a full recovery from a dangerous and potentially fatal disease. To our knowledge, this is the first case of imported MVE presenting outside the disease's accepted geographic range of the Australian continent and Papua New Guinea. Given the severe nature of MVE virus infection and expanding international travel and backpacker tourism, more cases may occur outside Australia in the future. Broad-range antibody tests for flaviviral infection might help suggest the diagnosis even in places where MVE-specific assays are not available, although accurate laboratory confirmation of the diagnosis should be sought. Tourists traveling through areas in which MVE is endemic should be aware of the potential risk and should take appropriate precautions.
